(Q36861628)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17594193%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

review article

1 reference

title

Tacrolimus in the treatment of idiopathic nephrotic syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17594193%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17594193%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Markus van der Giet

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17594193%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Timm H Westhoff

series ordinal

1

1 reference

16 August 2017

Markus van der Giet

series ordinal

2

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 July 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17594193%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Investigational Drugs

1 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17594193%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17594193%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17594193%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

1099-1110

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17594193%20AND%20SRC:MED&resulttype=core&format=json

Primary focal segmental glomerulosclerosis: clinical course and response to therapy

1 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

Adult-onset minimal change nephrotic syndrome: a long-term follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

Predicting the response to cytotoxic therapy for childhood nephrotic syndrome: superiority of response to corticosteroid therapy over histopathologic patterns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

Leukemia following chemotherapy for ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

Mycophenolate mofetil treatment for primary glomerular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

Mycophenolate mofetil in the treatment of resistant idiopathic nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

Long-term cyclosporine A treatment of steroid-resistant and steroid-dependent nephrotic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

Cyclosporine A induced remission of relapsing nephrotic syndrome in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

Cyclosporine A and chlorambucil in the treatment of idiopathic focal segmental glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

Novel therapy of focal glomerulosclerosis with mycophenolate and angiotensin blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

Acute rapamycin nephrotoxicity in native kidneys of patients with chronic glomerulopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

Idiopathic membranous nephropathy: outline and rationale of a treatment strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

A review of therapeutic studies of idiopathic membranous glomerulopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

Use of mycophenolate mofetil in resistant membranous nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

Membranoproliferative Glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

Clinical use of tacrolimus (FK-506) in infants and children with renal transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

Diadenosine polyphosphates increase cytosolic calcium and attenuate angiotensin-II-induced changes of calcium in vascular smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

Pharmacology of calcineurin antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

Calcineurin mediates alpha-adrenergic stimulation of Na+,K(+)-ATPase activity in renal tubule cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

FK-506 and cyclosporin A inhibit highly similar signal transduction pathways in human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

TGF-beta expression in renal transplant biopsies: a comparative study between cyclosporin-A and tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

Comparative clinical pharmacokinetics of tacrolimus in paediatric and adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

Effect of race and immunosuppression in renal transplantation: three-year survival results from a US multicenter, randomized trial. FK506 Kidney Transplant Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

Review: metabolism of immunosuppressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

FK 506 in steroid-resistant focal sclerosing glomerulonephritis of childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

Effective therapy of a child case of refractory nephrotic syndrome with tacrolimus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

Acute lymphoblastic leukemia in a child with nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

Tacrolimus-induced HUS: an unusual cause of acute renal failure in nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

Tacrolimus therapy in pediatric patients with treatment-resistant nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

Use of tacrolimus in steroid- and cyclophosphamide-resistant minimal change nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

Combination therapy with sirolimus (rapamycin) and tacrolimus (FK-506) in treatment of refractory minimal change nephropathy, a clinical case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

Effect of immunoadsorption on refractory idiopathic focal and segmental glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

A renal allograft recipient with late recurrence of focal and segmental glomerulosclerosis after switching from cyclosporine to tacrolimus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

Combined therapy of tacrolimus and corticosteroids in cyclosporin-resistant or -dependent idiopathic focal glomerulosclerosis: a preliminary uncontrolled study with prospective follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

Combined therapy of low-dose tacrolimus and prednisone in nephrotic syndrome with slight mesangial proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

Tacrolimus and posttransplant diabetes mellitus in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

Immunosuppression for long-term maintenance of renal allograft function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

Topical tacrolimus in the treatment of inverse psoriasis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

Cyclosporine a slows the progressive renal disease of alport syndrome (X-linked hereditary nephritis): results from a canine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

Sirolimus Therapy of Focal Segmental Glomerulosclerosis Is Associated With Nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.1099

10.1517/13543784.16.7.1099

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17594193%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference